A new RHCE variant allele, RHCE*48C,1170T,1193A.

Transfusion

Research and Development and the, Héma-Québec, Québec, Québec, Canada.

Published: July 2016

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.13629DOI Listing

Publication Analysis

Top Keywords

rhce variant
4
variant allele
4
allele rhce*48c1170t1193a
4
rhce
1
allele
1
rhce*48c1170t1193a
1

Similar Publications

Background: The Rh blood group system (ISBT004) is encoded by two homologous genes, RHD and RHCE. Polymorphism in these two genes gives rise to 56 antigens, which are highly immunogenic and clinically significant. This study extended previous work on the establishment of RHD allele specific reference sequences using next generation sequencing (NGS) with the Ion Personal Genome Machine (Ion PGM) to sequence the complete RHCE gene.

View Article and Find Full Text PDF
Article Synopsis
  • Many Omani patients with sickle cell disease mainly receive red blood cell transfusions that only account for ABO and D blood types, making them at high risk for alloimmunization.
  • The study aims to enhance transfusion compatibility by using molecular techniques to predict the extended antigen profiles across multiple blood group systems for Omani patients.
  • Initial findings indicate that the most common blood type among the enrolled 38 patients is group O, highlighting significant differences in RBC phenotypes compared to SCD patients in other regions.
View Article and Find Full Text PDF

Objective: To explore the Rh genotype for a female with RhD(-) blood type and its molecular basis.

Methods: A 26-year-old female who had attended the outpatient clinic of the First Affiliated Hospital of Zhengzhou University in August 2019 was selected as the study subject. Peripheral blood samples were collected from the proband and her parents for Rh phenotyping with gel card method.

View Article and Find Full Text PDF

Investigation of Delayed Transfusion Reactions in Sickle Cell Disease Patients Polytransfused in the Brazilian Amazon.

Hematol Rep

August 2024

Programa de Pós-Graduação em Ciências Aplicadas à Hematologia da Universidade do Estado do Amazonas (PPGH-UEA), Manaus 69050-001, AM, Brazil.

Background: Sickle cell disease (SCD) affects approximately 100,000 people in the United States and millions worldwide, with the highest prevalence of 70% of SCD being found in individuals of African ethnicity. Delayed hemolytic, alloimmunization, and anamnestic transfusion reactions in multiple transfusion patients need to be investigated and managed to avoid a worsening of the patient's clinical status.

Objective: This paper aims to investigate delayed transfusion reactions in SCD patients who were polytransfused in the Brazilian Amazon.

View Article and Find Full Text PDF

Anti-D can occur in D-positive patients who inherit RHD genetic variants encoding partial D antigen expression, but unexpected anti-D is also found in the plasma of patients with sickle cell disease who have conventional RHD gene(s) and are transfused with units from Black donors. These anti-D are likely stimulated by variant Rh expressed on donor cells; however, patients with anti-D, regardless of cause, are transfused for a lifetime with D-negative (Rh-negative) blood. This results in significant increased use of Rh-negative units, especially for those requiring chronic transfusion, which can strain Rh-negative blood inventories.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!